UBS Group’s Humacyte HUMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.11M | Buy |
2,445,471
+1,019,616
| +72% | +$2.13M | ﹤0.01% | 3039 |
|
|
2025
Q1 | $2.43M | Buy |
1,425,855
+304,303
| +27% | +$519K | ﹤0.01% | 3568 |
|
|
2024
Q4 | $5.66M | Buy |
1,121,552
+937,539
| +509% | +$4.73M | ﹤0.01% | 2868 |
|
|
2024
Q3 | $1M | Buy |
184,013
+60,210
| +49% | +$328K | ﹤0.01% | 3592 |
|
|
2024
Q2 | $594K | Buy |
123,803
+29,618
| +31% | +$142K | ﹤0.01% | 3811 |
|
|
2024
Q1 | $293K | Buy |
94,185
+9,231
| +11% | +$28.7K | ﹤0.01% | 4458 |
|
|
2023
Q4 | $241K | Buy |
84,954
+51,538
| +154% | +$146K | ﹤0.01% | 4476 |
|
|
2023
Q3 | $97.9K | Buy |
33,416
+433
| +1% | +$1.27K | ﹤0.01% | 4729 |
|
|
2023
Q2 | $94.3K | Buy |
32,983
+12,399
| +60% | +$35.5K | ﹤0.01% | 5003 |
|
|
2023
Q1 | $63.6K | Buy |
20,584
+17,470
| +561% | +$54K | ﹤0.01% | 5191 |
|
|
2022
Q4 | $6.57K | Sell |
3,114
-6,713
| -68% | -$14.2K | ﹤0.01% | 7822 |
|
|
2022
Q3 | $32K | Buy |
9,827
+4,710
| +92% | +$15.3K | ﹤0.01% | 5712 |
|
|
2022
Q2 | $16K | Buy |
+5,117
| New | +$16K | ﹤0.01% | 6156 |
|
|
2022
Q1 | – | Sell |
-241,374
| Closed | -$1.75M | – | 9340 |
|
|
2021
Q4 | $1.75M | Buy |
241,374
+240,596
| +30,925% | +$1.74M | ﹤0.01% | 2981 |
|
|
2021
Q3 | $9K | Buy |
778
+237
| +44% | +$2.74K | ﹤0.01% | 6943 |
|
|
2021
Q2 | $6K | Buy |
+541
| New | +$6K | ﹤0.01% | 7338 |
|
|
2021
Q1 | – | Sell |
-335
| Closed | -$3K | – | 8049 |
|
|
2020
Q4 | $3K | Buy |
+335
| New | +$3K | ﹤0.01% | 6970 |
|